Sponsor study identifier
Secondary identifiers
interventional
N/A
0 countries
N/A
Study Start
July 1989
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
January 1996
Date type not reportedThis date has not been verified as actual or estimated.
OBJECTIVES: I. Evaluate insulin resistance in thin and obese hyperandrogenic women with polycystic ovarian disease or hyperandrogenism insulin resistance acanthosis nigricans syndrome and in thin and obese controls, using an estimation of tissue sensitivity to insulin. II. Evaluate the effect of androgen suppression with leuprolide acetate and spironolactone on insulin secretion and resistance.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 1996
Date type not reportedThis date has not been verified as actual or estimated.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 1989
Date type not reportedThis date has not been verified as actual or estimated.
January 1996
Date type not reportedThis date has not been verified as actual or estimated.
October 18, 1999
Actual (reported)October 19, 1999
Actual (reported)Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Karen E. Elkind-Hirsch
Baylor College of Medicine
First Submitted
October 18, 1999
First Posted
October 19, 1999
Study Start
July 1989
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
January 1996
Date type not reportedThis date has not been verified as actual or estimated.
Last Updated
June 24, 2005
Record last verified: 2000-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: